Centene Addresses ‘Challenges’ in California’s Medi-Cal Rx Launch

Published On: April 28, 2022

Centene CEO Sarah London addressed concerns surrounding a subsidiary’s implementation of California’s new Medicaid prescription drug program after news reports chronicled members struggling to get access and approvals to needed medications.

Continue reading here on HealthCare Dive.

Subscribe To Our Newsletter

Get the latest cancer policy news and updates from COPA direct to your inbox.

We respect your policy and will never share your e-mail address.